E46: Rituximab in Lupus

The Evidence Based Rheumatology Podcast

Content provided by Michael Putman. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michael Putman or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

4+ y ago 22:25

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on April 25, 2022 17:24 (2y ago). Last successful fetch was on November 05, 2021 00:25 (2+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Finally got around to tackling rituximab in SLE. This is a tough topic: lots of people feel passionately one way or another, flawed observational data supports its use, flawed RCTs did not find significant benefit, and patients are left in the lurch. I tried my best and came away more confident than ever that there's no clear answer. I hope you enjoy; please send me feedback on twitter @ebrheum!

83 episodes

#Biology #Environment #Fitness #Michael Putman #Medicine #Science